How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree

How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree

Vaccine stocks Pfizer and BioNTech crept higher late Monday after the Food and Drug Administration authorized their Covid vaccines for adolescents ages 12-15 years old.